Inventor · disambiguated record
Stewart Kroll
Also filed as: KROLL STEWART · KROLL STEWART M
3 granted patents·9 pending applications·23 citations·filing 2005–2024
66Inventor score
Files withTHRESHOLD PHARMACEUTICALS INC3CURD KAREN2KROLL STEWART2HANDISIDES DAMIAN1IMMUNOGENESIS INC1
Top patents by PatentIndex Score
12 records- 0187US7668662B2Patient-specific dosimetryUNIV MICHIGAN·Filed 2005·Granted Feb 23, 2010·15 cites·28 claims
- 0279US8946275B2Treatment of cancer using hypoxia activated prodrugsKROLL STEWART·Filed 2009·Granted Feb 3, 2015·8 cites·18 claims
- 0375US2025295869A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerIMMUNOGENESIS INC·Filed 2024·Application pending·0 cites
- 0461US2019060275A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerMOLECULAR TEMPLATES INC·Filed 2018·Application pending·0 cites
- 0559US8765690B2Treatment of cancer with glufosfamide in patients not receiving insulin therapyHANDISIDES DAMIAN·Filed 2008·Granted Jul 1, 2014·0 cites·10 claims
- 0657US2015272973A1Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin TherapyTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0753US2014010805A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerCURD KAREN·Filed 2011·Application pending·0 cites
- 0850US2015258125A1Treatment of cancer using hypoxia activated prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0940US2017232017A1Treatment of cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1039US2016045522A1Treatment of CancerKROLL STEWART·Filed 2013·Application pending·0 cites
- 1136US2013296273A1Treatment of blood cancerCURD KAREN·Filed 2011·Application pending·0 cites
- 1235US2014072624A1Unit dose form for oral administrationJUNG DONALD·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stewart Kroll files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →